Artal Group S.A. Hookipa Pharma Inc. Transaction History

Artal Group S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.71 - $1.97 $2.71 Million - $7.52 Million	3,816,794 Added 206.36%	5,666,410 $4.99 Million
Q1 2022 May 12, 2022	BUY	$1.26 - $2.52 $1.58 Million - $3.15 Million	1,250,000 Added 208.47%	1,849,616 $4.22 Million
Q1 2021 May 14, 2021	SELL	$10.64 - $14.7 $3.72 Million - $5.15 Million	-350,000 Reduced 36.86%	599,616 $8.07 Million
Q4 2020 Feb 11, 2021	BUY	$9.32 - $13.63 $3.26 Million - $4.77 Million	350,000 Added 58.37%	949,616 $10.5 Million
Q2 2020 Aug 14, 2020	SELL	$7.23 - $12.1 $1.42 Million - $2.38 Million	-196,643 Reduced 24.7%	599,616 $6.97 Million
Q1 2020 May 14, 2020	SELL	$5.9 - $13.8 $1.23 Million - $2.88 Million	-208,728 Reduced 20.77%	796,259 $6.57 Million
Q4 2019 Feb 13, 2020	SELL	$6.51 - $12.23 $843,884 - $1.59 Million	-129,629 Reduced 11.42%	1,004,987 $12.3 Million
Q2 2019 Aug 09, 2019	BUY	$6.16 - $14.15 $6.99 Million - $16.1 Million	1,134,616 New	1,134,616 $7.64 Million

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $98.7M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.